APA (7th ed.) Citation

Atalay, S., Berends, S. E., Groenewoud, H. M. M., Mathot, R. A. A., Njoo, D. M., Mommers, J. M., . . . Reek, J. M. P. A. v. d. Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: Results of the CONDOR trial. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Atalay, Selma, et al. Serum Drug Levels and Anti-drug Antibodies in the Context of Dose Tapering by Interval Prolongation of Adalimumab, Etanercept and Ustekinumab in Psoriasis Patients: Results of the CONDOR Trial. Taylor & Francis Group.

MLA (9th ed.) Citation

Atalay, Selma, et al. Serum Drug Levels and Anti-drug Antibodies in the Context of Dose Tapering by Interval Prolongation of Adalimumab, Etanercept and Ustekinumab in Psoriasis Patients: Results of the CONDOR Trial. Taylor & Francis Group.